Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

560 recalls, newest first

Class II · Moderate risk

Icosapent Ethyl Capsules

Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

Ongoing Failed specification Zydus Pharmaceuticals (USA) Inc D-0400-2026
Class II · Moderate risk

Product label: Temozolomide Capsules

Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

Ongoing Impurity / degradation Rising Pharma Holding, Inc. NDC 16571-816-51 D-0384-2026

Recalls by year